J. Pohl

发表

Basis and new developments in the field of oxazaphosphorines.

H. Sindermann, N. Brock, P. Hilgard, 1988, Cancer investigation.

Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.

P. Hilgard, J. Pohl, J. Stekar, 1989, Arzneimittel-Forschung.

The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challenges

J. Engel, P. Hilgard, J. Pohl, 2005, Journal of Cancer Research and Clinical Oncology.

Oxazaphosphorine toxicity reduction by mesna.

P. Hilgard, J. Pohl, 1990, Cancer treatment reviews.

Oxazaphosphorines as biological response modifiers--experimental and clinical perspectives.

R. Voegeli, P. Hilgard, J. Pohl, 1985, Cancer treatment reviews.

Investigation into the immunological effects of miltefosine, a new anticancer agent under development

P. Hilgard, L. Nolan, T. Reissmann, 2005, Journal of Cancer Research and Clinical Oncology.

Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis.

T. Chalmers, J. Pohl, D. S. Platt, 1969, Annals of the rheumatic diseases.

alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agent.

P. Hilgard, M. Peukert, J. Pohl, 1984, Cancer treatment reviews.

Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.

M. Przybylski, N. Brock, P. Hilgard, 1985, Biomedical mass spectrometry.

Antineoplastic activity of ASTA Z 7557 (NSC-345842, INN mafosfamide) on transplantable murine tumors

P. Hilgard, G. Atassi, J. Pohl, 2004, Investigational New Drugs.

Therapeutic Efficacy of Oxazaphosphorines by Immunomodulation

R. Voegeli, P. Hilgard, T. Reissmann, 1986 .

[Separation and pharmaco-toxicological studies of the enantiomers of Ifosfamide].

G. Blaschke, J. Maibaum, P. Hilgard, 1986, Arzneimittel-Forschung.